Neurona Therapeutics’ Post

It's your last chance to register for our webinar with Thermo Fisher Scientific on May 16 📅 'Overcoming Cell Therapy Production Challenges: Maximizing Quality Assurance Through Rapid Sterility Testing' Register for FREE here! 👉 https://bit.ly/4dbwcuf #pharma #celltherapy #qualityassurance

Seeking to develop your workflow for T cell immunotherapies? In this article we discuss technologies used in the complex ex vivo workflow for CAR T, including pharmaceutical analytical tools to help ensure your therapy is regulatory compliant: https://lnkd.in/ebmppYD3 #bioprocessing #bioproduction #qualitycontrol #regulatorycontrol #celltherapy #genetherapy #analyticaltesting 

Seeking to develop your workflow for T cell immunotherapies? In this article we discuss technologies used in the complex ex vivo workflow for CAR T, including pharmaceutical analytical tools to help ensure your therapy is regulatory compliant: https://lnkd.in/ebmppYD3 #bioprocessing #bioproduction #qualitycontrol #regulatorycontrol #celltherapy #genetherapy #analyticaltesting 

Seeking to develop your workflow for T cell immunotherapies? In this article we discuss technologies used in the complex ex vivo workflow for CAR T, including pharmaceutical analytical tools to help ensure your therapy is regulatory compliant: https://lnkd.in/ebmppYD3 #bioprocessing #bioproduction #qualitycontrol #regulatorycontrol #celltherapy #genetherapy #analyticaltesting

Thoughts on this? >> ProKidney axes one Phase 3 study, aims for 'expedited approval pathway' using another >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #productmarketing #biotech

Explore key challenges that come with the development of cell and gene-modified cell therapies. From navigating CMC challenges to ensuring a smooth transition from preclinical processes to GMP, download our whitepaper to learn all of the critical elements required for success. https://okt.to/C4bH6q #celltherapy #genemodified #CDMO

Thoughts on this? >> ProKidney axes one Phase 3 study, aims for 'expedited approval pathway' using another >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #productmarketing #pharmaceutical

Explore key challenges that come with the development of cell and gene-modified cell therapies. From navigating CMC challenges to ensuring a smooth transition from preclinical processes to GMP, download our whitepaper to learn all of the critical elements required for success. https://okt.to/AHJxNE #celltherapy #genemodified #CDMO

In a surprising development, the FDA's directive for a labeling alteration concerning Gilead Sciences' Tecartus briefly disappeared from the agency's website. The FDA did not remove the CD19 CAR-T therapy from a broader safety alert. Instead, it opted to refine the language of a proposed boxed warning. The revised communication insists that Gilead's cell therapy unit, Kite Pharma, incorporate updated language addressing the risk of T-cell malignancies into Tecartus' label, no longer explicitly mentioning Tecartus patients experiencing T-cell malignancies as in the original proposal. #FDA #GileadSciences #Tecartus #CARTtherapy #healthcare #lifesciences